Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Belani

Showing results (101-110 of 298) with videos related to

Pageof 30
Sort By:
Journal of Palliative Medicine|December 19, 2014
Complex chronic conditions in Rhode Island's pediatric populace: implications for palliative and hospice services, 2000-2012Daniel S Jamorabo, Chandra P Belani, Edward W Martin
Medical and Pediatric Oncology|January 1, 1988
Preliminary experience with chemotherapy in advanced salivary gland neoplasmsC P Belani, M A Eisenberger, W C Gray
Seminars in Oncology|October 1, 1996
Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I studyC P Belani, J Aisner, D Hiponia, et al.
Cancer Investigation|May 11, 2012
Primary and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: an updateAyodele Ayoola, Amit Barochia, Kiran Belani, et al.
Current Opinion in Oncology|December 1, 1989
Platinum compoundsC P Belani, D A Van Echo, J Aisner
Lung Cancer (Amsterdam, Netherlands)|November 7, 2006
Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical researchChandra P Belani, Sherry Marts, Joan Schiller, et al.
Archives of Internal Medicine|February 1, 1989
Tamoxifen withdrawal response. Report of a caseC P Belani, P Pearl, N O Whitley, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|April 10, 2016
Pulmonary Rehabilitation in Lung CancerHongmei Wang, Xin Liu, Shawn J Rice, et al.
Proteomics|December 27, 2018
Absolute Quantification of All Identified Plasma Proteins from SWATH Data for Biomarker DiscoveryShawn J Rice, Xin Liu, Jianhong Zhang, et al.
Plos One|June 1, 2019
EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancerShawn J Rice, Xin Liu, Hong-Gang Wang, et al.
Pageof 30

Showing results (101-110 of 298) with videos related to

Sort By:
Pageof 30
Journal of Palliative Medicine|December 19, 2014
Complex chronic conditions in Rhode Island's pediatric populace: implications for palliative and hospice services, 2000-2012Daniel S Jamorabo, Chandra P Belani, Edward W Martin
Medical and Pediatric Oncology|January 1, 1988
Preliminary experience with chemotherapy in advanced salivary gland neoplasmsC P Belani, M A Eisenberger, W C Gray
Seminars in Oncology|October 1, 1996
Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I studyC P Belani, J Aisner, D Hiponia, et al.
Cancer Investigation|May 11, 2012
Primary and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: an updateAyodele Ayoola, Amit Barochia, Kiran Belani, et al.
Current Opinion in Oncology|December 1, 1989
Platinum compoundsC P Belani, D A Van Echo, J Aisner
Lung Cancer (Amsterdam, Netherlands)|November 7, 2006
Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical researchChandra P Belani, Sherry Marts, Joan Schiller, et al.
Archives of Internal Medicine|February 1, 1989
Tamoxifen withdrawal response. Report of a caseC P Belani, P Pearl, N O Whitley, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|April 10, 2016
Pulmonary Rehabilitation in Lung CancerHongmei Wang, Xin Liu, Shawn J Rice, et al.
Proteomics|December 27, 2018
Absolute Quantification of All Identified Plasma Proteins from SWATH Data for Biomarker DiscoveryShawn J Rice, Xin Liu, Jianhong Zhang, et al.
Plos One|June 1, 2019
EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancerShawn J Rice, Xin Liu, Hong-Gang Wang, et al.
Pageof 30